Skip to content

Latest

Pepsi is more than OK in new Super Bowl ad campaign

Pepsi is more than OK in new Super Bowl ad campaign

Pepsi is no stranger to the Super Bowl and this year, the brand is using the world’s biggest stage to answer the question “Is Pepsi OK?,” showing the world – and the internet – once and for all that Pepsi is so much “more than OK!” The brand’s highly anticipated in-game advertisement, “More

ACPE elects new officers, announces new board members

ACPE elects new officers, announces new board members

CHICAGO – The Accreditation Council for Pharmacy Education (ACPE) announced that Lori Duke, Anthony Provenzano, and Michael Moné have been elected as members of the ACPE executive committee for the 2019–2020 term of office.

Dr. Reddy’s gets FDA approval for Tosymra

Dr. Reddy’s gets FDA approval for Tosymra

Dr. Reddy’s Laboratories and its subsidiary, Promius Pharma. today announced the approval of Tosymra (previously known as DFN-02) by the U.S. Food and Drug Administration (FDA). Tosymra is indicated for the acute treatment of migraine with or without aura in adults.

Rite Aid announces plans for reverse stock split

Rite Aid announces plans for reverse stock split

CAMP HILL, PA – Rite Aid Corp. announced today that its board of directors has approved a reverse stock split of the company’s common stock. The reverse stock split is intended to enable Rite Aid to regain full compliance with the New York Stock Exchange (NYSE) listing rules.

Pepsi to launch new nitrogen-infused drink called “Nitro Pepsi”

Pepsi to launch new nitrogen-infused drink called “Nitro Pepsi”

Pepsi has announced the roll out of a nitrogen-infused version of its trademark soda called “Nitro Pepsi.” With a promising “velvety, cascading foam,” Nitro Pepsi aims to replicate that drinking experience as the “world’s first nitrogen-infused soda” in two flavors: Classic Soda and Vanilla.

NACDS demonstrates need for DIR fee reform in comments to CMS

NACDS demonstrates need for DIR fee reform in comments to CMS

Based on insights from member pharmacies that serve as the front lines of healthcare delivery, the National Association of Chain Drug Stores (NACDS) has submitted extensive and thoroughly documented comments to the Centers for Medicare & Medicaid Services in support of the agency’s proposal to refor